The Relationship Between Blood Pressure Salt Sensitivity and Metabolic Syndrome

Abstract

Blood pressure salt sensitivity (BPSS) is a physiological trait characterized by significant changes in blood pressure in response to 
dietary sodium intake. Emerging evidence suggests that BPSS is closely associated with metabolic abnormalities and may represent 
an early marker of cardiometabolic risk. This study explores the relationship between blood pressure salt sensitivity and metabolic 
syndrome (MetS), a cluster of conditions including central obesity, insulin resistance, dyslipidemia, and hypertension.

Salt-sensitive individuals often exhibit impaired renal sodium handling, endothelial dysfunction, heightened sympathetic nervous 
system activity, and activation of the renin–angiotensin–aldosterone system. These mechanisms overlap with the pathophysiological pathways underlying metabolic syndrome. Insulin resistance, a core feature of MetS, may enhance renal sodium reabsorption and contribute to increased vascular stiffness, thereby amplifying salt-induced blood pressure responses. Furthermore, chronic low grade inflammation and oxidative stress—common in metabolic syndrome—may exacerbate vascular reactivity to sodium. 

Clinical and epidemiological data indicate that individuals with metabolic syndrome are more likely to demonstrate salt sensitivity 
and are at higher risk of cardiovascular complications, including left ventricular hypertrophy, stroke, and chronic kidney disease. 
Identifying salt-sensitive phenotypes within patients with metabolic syndrome may facilitate personalized dietary sodium 
recommendations and targeted therapeutic interventions.

Understanding the interplay between BPSS and metabolic syndrome has significant implications for prevention strategies in diabetes and endocrinology practice. Early detection and lifestyle modification, particularly sodium restriction and weight management, may reduce long-term cardiometabolic morbidity and mortality.